Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ted Yednock Insider Profile
4 Followers
Ted Yednock, EVP & CHIEF INNOVATION OFFICER at Annexon Biosciences, holds 71.36K shares in Annexon Biosciences (Ticker: ANNX).
Ted Yednock Annexon Biosciences (ANNX)EVP & CHIEF INNOVATION OFFICER
Annexon Biosciences (ANNX)
EVP & CHIEF INNOVATION OFFICER
Ranked #41,982 out of 99,797 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+3.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP & CHIEF INNOVATION OFFICER
Roles that Ted Yednock holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ted Yednock
Ted Yednock's Trading History
List of latest transactions for each holding click on a transaction to see Ted Yednock's performance on stock
You May Also Like
Ted Yednock insider profile FAQ
What is the percentage of profitable transactions made by Ted Yednock?
The percentage of profitable transactions made by Ted Yednock is 67%.
What is the average return per transaction made by Ted Yednock?
The average return per transaction made by Ted Yednock is 3.90%.
What stocks does Ted Yednock hold?
Ted Yednock holds: ANNX stocks.
What was Ted Yednock’s latest transaction?
Ted Yednock latest transaction was an Uninformative Buy of $10.00K.
What was Ted Yednock's most profitable transaction?
Ted Yednock’s most profitable transaction was an Informative Sell of ANNX stock on July 17, 2024. The return on the trade was 13.10%.
What is Ted Yednock's role in Annexon Biosciences?
Ted Yednock's role in Annexon Biosciences is EVP & CHIEF INNOVATION OFFICER.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.